BENGALURU: The special cabinet meeting chaired by Chief Minister Siddaramaiah in Bengaluru on Tuesday decided to implement the ambitious Upper Krishna Project (UKP) Phase-3. The project requires 1.33 ...

Candel is a clinical-stage biopharmaceutical company focused on developing off-the-shelf, multimodal viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help ...

(NEXSTAR) – A multi-phase scam credited with emptying the financial accounts of numerous Americans – many of whom were nearing the age of retirement – is again making headlines after the FBI recently ...

Abstract: This article presents a single-stage electrolytic capacitor-less AC-DC converter designed for EV chargers, featuring a 6-switch full-bridge DC side configuration with both three-phase and ...

CHARLESTON, S.C. (WCIV) — A major new chapter in Charleston’s urban development is taking shape as the City’s Board of Architectural Review considers the conceptual plans for Phase 3 of the Courier ...

The consultation period for setting up electric vehicle charging ports has one week left before closing to the public, the Government has announced. The National Electric Vehicle Charging ...

Abstract: The dual-active-bridge-based three-phase single-stage ac–dc converter has gained significant attention in power conversion applications due to its superior efficiency and compact volume.

A phase 1/2 open-label, multicenter, first-in-human study of the safety, tolerability, pharmacokinetics, and antitumor activity of BH-30643 in adult subjects with locally advanced or metastatic NSCLC ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Oak Hill Bio, a biotechnology company focused on acquiring and developing life-changing rare disease therapeutics, has entered into an exclusive license agreement ...

William is a writer for GameRant who has been helping players solve problems for years. Don't know how to find that item or defeat that boss? He's got your back. To think, it all started with Sega's ...

Following a successful Type B end-of-phase 2 meeting, the FDA has approved the start of a phase 3 trial of linperlisib in peripheral T-cell lymphoma. The FDA has granted clearance to initiate a global ...